Latest colorectal News

FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
Gut microbiome: meet Clostridium butyricum – the bacteria that helps keep us feeling our best
Future Cancer Treatment And Fertility
Losing weight associated with an increased cancer risk – a closer look at the study
Hamming it up: What’s the verdict on processed meat?
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Vigilance needed to curb “entirely preventable” road deaths in 2024
Manchester researchers develop first ever guideline for cancer screening in rare muscle disease
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Aggressive colon tumor may be vulnerable to cholesterol therapy
Even small amounts of physical activity could be valuable in late-stage lung cancer
Kate teaches ‘Art from heART’ to Mater patients
Second da Vinci system supports surgery at Mater
Wellcome Trust funds study of innate immune cells role in intestinal health and disease
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
Genetic switches in tumor development
Asbestos still risk to workers 20 years on from ban
Starpharma announces the presentation of DEP irinotecan combination data
Proud Redlands City nurse celebrates 15 years of helping patients
FivepHusion says first patient treated in paediatric brain cancer trial
Robotic masterpiece arrives at Mater Mackay
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Engineering bacteria to detect cancer DNA
Colorectal cancer organizations unite in screening age recommendations
AGA stands firm in CRC screening age recommendations
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics
$1m supports immunology and microbiology researchers
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Ludwig Chicago study develops an innovative approach to classify metastases in colorectal cancer patients
One month after UnitedHealthcare’s “advance notification” program began, confusion still reigns for America’s GI doctors
First patient dosed in study of TLX250-CDx exploring indication expansion
Young Qld mum Amanda warns ‘bowel cancer doesn’t discriminate’
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Despite last minute change, UnitedHealthcare’s policy for virtually all colonoscopies and endoscopies lays groundwork for delays, disruptions, and denials of life-saving services
Karen living proof that screening saves lives: Why you should ‘Get2it’, too
Double testing better at identifying bowel cancer
Gene p16 drives colorectal cancer, potential therapy target
Artificial intelligence to predict chemotherapy toxicities in colon cancer patients
Carina Biotech to present details of planned trial of CAR-T cell therapy candidate
Time is running out: patients, physicians brace for anticipated delays, denials by UnitedHealthcare for endoscopies starting June 1
Time is running out: patients, physicians brace for anticipated delays, denials by UnitedHealthcare for endoscopies starting June 1
First patient on trial in colorectal, gastric and ovarian cancer study
Using right test for right person to detect bowel cancer
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
3D bioprinting inside the human body could be possible thanks to new soft robot
Karen’s simple test that saved her life
GTG to form strategic alliance with global testing leader QIAGEN
Ludwig Harvard imaging study reveals cellular, molecular and structural complexity of colorectal tumors